Worth reading
41Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
Video of the “Bio IR DAY” IR seminar for individual investors
Applicable field (uses covered by this announcement)
IR and corporate information presentations for individual investors
Launch date7 April 2026; video released
Relationship between the counterparty and the company
K Pharma,Inc.4896
Relationship with the Company
株式会社日本証券新聞社 organized the seminar, and the company participated and gave a presentation.
Counterparty株式会社日本証券新聞社
Organizer of the IR seminar for individual investors. Other details: Not disclosed
Location (as indicated in this announcement)
Asahi Life Hall (8th Floor, Osaka Asahi Life Building)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Video of the “Bio IR DAY” IR seminar for individual investors |
| Counterparty | 株式会社日本証券新聞社 |
| Counterparty overview | Organizer of the IR seminar for individual investors. Other details: Not disclosed |
| Relationship with the Company | 株式会社日本証券新聞社 organized the seminar, and the company participated and gave a presentation. |
| Launch date | 7 April 2026; video released |
| Applicable area | IR and corporate information presentations for individual investors |
| Location | Asahi Life Hall (8th Floor, Osaka Asahi Life Building) |
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To enable individual investors to view the video.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.